<DOC>
	<DOCNO>NCT02561767</DOCNO>
	<brief_summary>This study design determine efficacy safety allogeneic bone marrow-derived mesenchymal stem cell kidney transplantation Chinese donation citizen 's death ( DCD ) . A pair uremia patient receive kidney graft donor randomize two group : MSCs group control group . Besides routine induction therapy ( ATG Basiliximab ) maintenance immunosuppressive drug ( low-dose Tacrolimus + MPA + prednisone ) , patient MSCs group administer MSCs treatment ( 1*10^6/kg ) . Allogeneic bone marrow-derived MSCs ( 1*10^6/kg ) give intravenously day 0 ( post renal reperfusion surgery ) , day 7 , day 14 day 21 . The renal allograft function , rejection , patient/graft survival severe adverse event within 12 month post-transplant monitor .</brief_summary>
	<brief_title>Effect BM-MSCs DCD Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Kidney Tubular Necrosis , Acute</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>1 . Primary kidney transplantation 2 . Receiving induction therapy combine immunosuppressive regimen ( CNIs + MPA + steroid ) 3 . Patient willing capable give write informed consent study participation able participate study 12 month 1 . Secondary kidney transplantation 2 . Combined multiorgan transplantation 3 . Women pregnant , intend become pregnant next 1 year , breastfeeding , positive pregnancy test enrollment prior study medication administration 4 . Panel reactive antibody ( PRA ) &gt; 20 % 5 . CDC crossmatch positive 6 . Donors recipient know hepatitis C antibodypositive polymerase chain reaction ( PCR ) positive hepatitis C 7 . Donors recipient know hepatitis B surface antigenpositive PCR positive hepatitis B 8 . Donors recipient know human immunodeficiency virus ( HIV ) infection 9 . Patients active infection 10 . Recipients history substance abuse ( drug alcohol ) within past 6 month , psychotic disorder capable adequate study followup . 11 . Patients severe cardiovascular dysfunction 12 . WBC &lt; 3*10^9/L RBC &lt; 5g/dL 13 . Highly allergic constitution severe history allergy . 14 . Patients active peptic ulcer disease , chronic diarrhea , gastrointestinal problem affect absorption 15 . Patients history cancer within last 5 year 16 . Prisoner patient compulsorily detain ( involuntarily incarcerate ) treatment either psychiatric physical ( e.g . infectious disease ) illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>kidney transplantation</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>donation citizen 's death</keyword>
	<keyword>ischemia reperfusion injury</keyword>
	<keyword>renal function recovery</keyword>
</DOC>